[go: up one dir, main page]

SE0102048D0 - New Compounds - Google Patents

New Compounds

Info

Publication number
SE0102048D0
SE0102048D0 SE0102048A SE0102048A SE0102048D0 SE 0102048 D0 SE0102048 D0 SE 0102048D0 SE 0102048 A SE0102048 A SE 0102048A SE 0102048 A SE0102048 A SE 0102048A SE 0102048 D0 SE0102048 D0 SE 0102048D0
Authority
SE
Sweden
Prior art keywords
compounds
new compounds
sulfonamide
substituted
prophylaxis
Prior art date
Application number
SE0102048A
Other languages
Swedish (sv)
Inventor
Ulf Bremberg
Patrizia Caldirola
Gary Johansson
Andrew Mott
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Priority to SE0102048A priority Critical patent/SE0102048D0/en
Publication of SE0102048D0 publication Critical patent/SE0102048D0/en
Priority to CA002445653A priority patent/CA2445653A1/en
Priority to PL02367264A priority patent/PL367264A1/en
Priority to IL15859002A priority patent/IL158590A0/en
Priority to KR1020087016920A priority patent/KR100888906B1/en
Priority to AU2002309435A priority patent/AU2002309435B2/en
Priority to MXPA03011083A priority patent/MXPA03011083A/en
Priority to KR1020097000129A priority patent/KR20090019894A/en
Priority to ZA200308097A priority patent/ZA200308097B/en
Priority to CNB028103777A priority patent/CN100457726C/en
Priority to YU98003A priority patent/YU98003A/en
Priority to PCT/SE2002/001126 priority patent/WO2002100822A1/en
Priority to BR0210291-9A priority patent/BR0210291A/en
Priority to CNA2008101812345A priority patent/CN101402601A/en
Priority to EA200400027A priority patent/EA008476B1/en
Priority to NZ529032A priority patent/NZ529032A/en
Priority to CNA2005101381444A priority patent/CN1800185A/en
Priority to KR1020037016203A priority patent/KR100889718B1/en
Priority to EP02778916A priority patent/EP1412325A1/en
Priority to JP2003503591A priority patent/JP4731114B2/en
Priority to US10/167,141 priority patent/US7144883B2/en
Priority to NO20035496A priority patent/NO20035496D0/en
Priority to HK04109896.2A priority patent/HK1066790A1/en
Priority to US11/510,324 priority patent/US7572787B2/en
Priority to US11/509,914 priority patent/US20070066598A1/en
Priority to US11/509,989 priority patent/US20070066599A1/en
Priority to JP2009209444A priority patent/JP2010013473A/en
Priority to US12/781,355 priority patent/US20100222330A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The present invention relates to substituted sulfonamide compounds of the general formula (I), wherein P is sulfonamide or amide-substituted sulfonic acid, which compounds are potentially useful for the prophylaxis and treatment of medical conditions relating to obesity, type II diabetes and/or disorders of the central nervous system.
SE0102048A 2001-06-11 2001-06-11 New Compounds SE0102048D0 (en)

Priority Applications (28)

Application Number Priority Date Filing Date Title
SE0102048A SE0102048D0 (en) 2001-06-11 2001-06-11 New Compounds
US10/167,141 US7144883B2 (en) 2001-06-11 2002-06-11 Bicyclic sulfonamide compounds
BR0210291-9A BR0210291A (en) 2001-06-11 2002-06-11 Substituted sulfonamide compounds, process for their preparation and use as a medicament for the treatment of central nervous system disorders, obesity and type II diabetes
EA200400027A EA008476B1 (en) 2001-06-11 2002-06-11 Substituted sulfonamide compounds, process for their use as medicaments for the treatment of cns disorders, obesity and type ii diabetes
IL15859002A IL158590A0 (en) 2001-06-11 2002-06-11 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes
KR1020087016920A KR100888906B1 (en) 2001-06-11 2002-06-11 Substituted sulfonamide compounds, their use as agents for treating CNS disorders, obesity and type II diabetes
AU2002309435A AU2002309435B2 (en) 2001-06-11 2002-06-11 Substituted sulfonamide compounds, process for their use as medicament for the treatment of CNS disorders, obesity and type II diabetes
MXPA03011083A MXPA03011083A (en) 2001-06-11 2002-06-11 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes.
KR1020097000129A KR20090019894A (en) 2001-06-11 2002-06-11 Substituted sulfonamide compounds, methods of use thereof as agents for treating CNS disorders, obesity and type II diabetes
ZA200308097A ZA200308097B (en) 2001-06-11 2002-06-11 Substituted sulfonamide compounds, process for their use as medicament for the treatment of CNS disorders, obesity and type II diabetes.
CNB028103777A CN100457726C (en) 2001-06-11 2002-06-11 Substituted sulfonamide compounds, process for their use as medicament for the treatment of CNS disorders, obestity and type II diabetes
YU98003A YU98003A (en) 2001-06-11 2002-06-11 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes
PCT/SE2002/001126 WO2002100822A1 (en) 2001-06-11 2002-06-11 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes
CA002445653A CA2445653A1 (en) 2001-06-11 2002-06-11 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes
CNA2008101812345A CN101402601A (en) 2001-06-11 2002-06-11 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes
PL02367264A PL367264A1 (en) 2001-06-11 2002-06-11 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes
NZ529032A NZ529032A (en) 2001-06-11 2002-06-11 Substituted sulfonamide compounds, process for their use as medicament for the treatment of CNS disorders, obesity and type II diabetes
CNA2005101381444A CN1800185A (en) 2001-06-11 2002-06-11 Substituted sulfonamide compounds, process for their use as medicament for the treatment of CNS disorders, obesity and type II diabetes.
KR1020037016203A KR100889718B1 (en) 2001-06-11 2002-06-11 Substituted sulfonamide compounds, their use as agents for treating CNS disorders, obesity and type II diabetes
EP02778916A EP1412325A1 (en) 2001-06-11 2002-06-11 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes
JP2003503591A JP4731114B2 (en) 2001-06-11 2002-06-11 Substituted sulfonamide compounds, methods for their use as medicaments for the treatment of CNS disorders, obesity and type II diabetes
NO20035496A NO20035496D0 (en) 2001-06-11 2003-12-10 Substituted Sulfonamide Compounds, Methods for Their Use as a Drug for the Treatment of CNS Disorders, Overweight and Type II Diabetes
HK04109896.2A HK1066790A1 (en) 2001-06-11 2004-12-14 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes
US11/510,324 US7572787B2 (en) 2001-06-11 2006-08-25 Substituted naphthalene sulfonamides
US11/509,914 US20070066598A1 (en) 2001-06-11 2006-08-25 Compounds
US11/509,989 US20070066599A1 (en) 2001-06-11 2006-08-25 New compounds
JP2009209444A JP2010013473A (en) 2001-06-11 2009-09-10 Substituted sulfonamide compound and its method of application as medicine for treatment of cns disorder, obesity, and diabetes mellitus type 2
US12/781,355 US20100222330A1 (en) 2001-06-11 2010-05-17 New Compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0102048A SE0102048D0 (en) 2001-06-11 2001-06-11 New Compounds

Publications (1)

Publication Number Publication Date
SE0102048D0 true SE0102048D0 (en) 2001-06-11

Family

ID=20284423

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0102048A SE0102048D0 (en) 2001-06-11 2001-06-11 New Compounds

Country Status (3)

Country Link
CN (1) CN101402601A (en)
SE (1) SE0102048D0 (en)
ZA (1) ZA200308097B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI754702B (en) * 2016-12-28 2022-02-11 德商Ｕｃｂ製藥有限公司 (aza)indole- and benzofuran-3-sulfonamides

Also Published As

Publication number Publication date
ZA200308097B (en) 2004-10-18
CN101402601A (en) 2009-04-08

Similar Documents

Publication Publication Date Title
MXPA03011083A (en) Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes.
MXPA03010232A (en) Novel, arylsusfonamide compounds for the treatment of obesity, type ii diabetes and cns-disorders.
EA200600975A1 (en) CONDENSED HETEROCYCLIC COMPOUNDS APPLICABLE FOR THE TREATMENT OF OBESITY AND DISORDERS OF THE CENTRAL NERVOUS SYSTEM
EA199900669A1 (en) INTERMEDIATE COMPOUNDS FOR OBTAINING N-[AMINOIMINOMETHYL OR AMINOMETHYL-PHENYL] SUBSTITUTED PROPYLAMIDES
EA200600048A1 (en) BENZAZEPIN DERIVATIVES USED TO TREAT DISEASES ASSOCIATED WITH 5-HT RECEPTOR
DK1438310T3 (en) Beta-carboline derivatives as PTP inhibitors
JO2764B1 (en) Indole derivatives or benzimidazole derivatives for modulating ikappab kinase
EA200301216A1 (en) MULTICYCLIC HETEROARYLS SUBSTITUTED WITH QUINUCLIDINES FOR THE DISEASE TREATMENT
BR0012450A (en) Substituted benzimidazoles
BRPI0408369A (en) indole derivatives useful for treating disease
BRPI0409109A (en) new compounds
NO20075781L (en) Diarylsulfone sulfonamides and their use
SE0303180D0 (en) Novel compounds
SE0302232D0 (en) Novel Compounds
SE0403006D0 (en) New compounds
NO20065079L (en) Materials and methods for the treatment of coagulation disorders
BR0213094A (en) Chroman derivatives as 5-hydroxy tryptamine-6 ligands
DK1456212T3 (en) 6-aminomorphinan derivatives, processes for their preparation and their use
EA200700848A1 (en) PI3-GAMMA KINASE INHIBITORS FOR THE TREATMENT OF ANEMIA
NO20060718L (en) Substituted thiophones and their use
NO20014241D0 (en) C16-unsaturated FP-selective prostaglandin analogs
DK1441724T3 (en) Method for increasing endogenous testosterone levels
SE0101082D0 (en) Novel use
ATE402694T1 (en) USE OF 1-PHENYL-3-DIMETHYLAMINO-PROPANE COMPOUNDS FOR THE THERAPY OF URINARY INCONTINENCE
BRPI0508927A (en) compounds useful for treating diseases